Basis of Presentation (Tables)

9 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of effects of misclassification

	Three Months Ended December 31, 2018
Dollars in thousands	As Previously Reported		Adjustment		As Revised
Total Company
Revenue
Products	$	141,732	$	(16,357)	$	125,375
Service		37,636		16,357		53,993
Total Revenue		179,368		—		179,368
Cost of revenue
Products		83,481		(8,907)		74,574
Service		23,806		8,907		32,713
Total cost of revenue	$	107,287	$	—	$	107,287
Brooks Life Science Segment
Revenue
Products	$	39,931	$	(16,357)	$	23,574
Service		26,730		16,357		43,087
Total Revenue	$	66,661	$	—	$	66,661